Mary Ann Liebert, Inc., publishers has announced that Kevin Davies has joined the company as Executive Vice President, Strategic Development. In this new role, Davies will oversee strategy development for the company's life science franchise, including GEN (Genetic Engineering & Biotechnology News) and Clinical OMICS, as well as spearhead innovative new content initiatives for Mary Ann Liebert, Inc.
Davies's career as an editor, author, and publisher has spanned more than 25 years. He has held a number of prominent editorial and publishing positions, including founding editor of Nature Genetics, Editor-in-Chief of Cell Press, launch editor for Bio-IT World, and vice president of the American Chemical Society, where he served as publisher of Chemical & Engineering News.
Davies is the author of three successful science books exploring the medical and societal impact of advances in DNA sequencing and analysis—Breakthrough: The Race to Find the Breast Cancer Gene; Cracking the Genome: The Race to Unlock Human DNA; and The $1,000 Genome: The Revolution in DNA Sequencing and the New Era of Personalized Medicine—as well as co-author with Nobel laureate Jim Watson of an updated edition of DNA: The Story of the Genetic Revolution. In April of this year, Davies won a prestigious Guggenheim Fellowship for science writing.
Brought to you by Scope e-Knowledge Center, a world-leading provider of Abstracting & Indexing (A&I) Services, Knowledge Modeling Services (Taxonomies, Thesauri and Ontologies), Metadata Enrichment & Entity Extraction Services.
